Repligen Corporation (RGEN) Reports Fourth Quarter and Full Year 2012 Financial Results and Provides Financial Guidance for 2013
3/7/2013 11:38:12 AM
More...
|
Repligen Corporation (RGEN) Enters Licensing Deal With Pfizer Inc. (PFE) Worth Up to $70 Million
1/3/2013 7:03:28 AM
More...
|
Repligen Corporation (RGEN) Reports Third Quarter 2012 Financial Results
11/8/2012 10:16:25 AM
More...
|
Repligen Corporation (RGEN) CEO to Present at Upcoming Investor Conferences
11/7/2012 9:56:10 AM
More...
|
Repligen Corporation (RGEN) to Report Third Quarter of 2012 Financial Results
10/26/2012 7:28:18 AM
More...
|
Repligen Corporation (RGEN) Appoints Jonathan I. Lieber as CFO
9/21/2012 10:12:48 AM
More...
|
Repligen Corporation (RGEN) to Present at Stifel Nicolaus Healthcare Conference 2012
8/29/2012 10:09:34 AM
More...
|
Repligen Corporation (RGEN) Announces Strategic Focus on Bioprocessing Business and Reports Second Quarter 2012 Financial Results
8/2/2012 10:42:11 AM
More...
|
Repligen Corporation (RGEN) to Report Second Quarter of 2012 Financial Results
7/24/2012 9:45:52 AM
More...
|
Repligen Corporation (RGEN) Release: Ronald L. Chez Files Amended 13D and Letter to the Board
7/23/2012 10:10:16 AM
More...
|
|